Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
Proinflammatory CD4+ T cells without the costimulatory molecule CD28 (CD4+CD28null T cells) are expanded in patients with end-stage renal disease (ESRD) and associated with atherosclerotic vascular events (AVE). In a prospective study, the number of circulating CD4+CD28null T cells was established i...
Saved in:
Main Authors: | Michiel G. H. Betjes, Willem Weimar, Nicolle H. R. Litjens |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Journal of Transplantation |
Online Access: | http://dx.doi.org/10.1155/2013/841430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Pathogenic Role of Expanded CD8⁺CD28<sup>null</sup> Angiogenic T Cells in ANCA-Associated Vasculitis
by: Haomiao Shen, et al.
Published: (2024-12-01) -
CD3+CD8+CD28− T Lymphocytes in Patients with Lupus Nephritis
by: Marcelina Żabińska, et al.
Published: (2016-01-01) -
The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?
by: Kathrin Maly, et al.
Published: (2015-01-01) -
Corrigendum to “The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?”
by: Kathrin Maly, et al.
Published: (2015-01-01) -
The Modulation of PPARγ1 and PPARγ2 mRNA Expression by Ciglitazone in CD3/CD28-Activated Naïve and Memory CD4+ T Cells
by: Mohd Nor Norazmi, et al.
Published: (2012-01-01)